DEINOVE is a French biotechnology company pioneering the exploration of a new domain of life, unexplored at 99.9%: microbial dark matter.
View all
GENFIT
Loos, France · Post IPO Equity
Algaia
Paris, France · Venture
DBV Technologies
Montrouge, France · Post IPO Equity
sunday
Paris, France · Series A
Worldcoin
Southbury, United States · Initial Coin Offering
Celsius Therapeutics
Cambridge, United States · Series B
WeMaintain
Paris, France · Series B
Homa Games
Paris, France · Series B
Convelio
Paris, France · Series B
Corporate Finance Institute
Vancouver, Canada · Funding Round
nfinite
Bordeaux, France · Series B
Dermavant Sciences
Long Beach, United States · Private Equity